Marc Raynaud 🇫🇷
@Raynaud_Maths
Followers
315
Following
662
Media
75
Statuses
222
Scientific lead of @ParisTxGroup
Paris, France
Joined September 2017
With @ParisTxGroup and @AlexandreLoupy, at #esot2025, we have officially announced the world’s FIRST AI TRANPLANT CLINIC that will be launched in 2026 !.It will be a revolution for precision diagnostics, prognostics, patient monitoring and therapeutic simulation !.#AI
1
3
17
Generate videos in just a few seconds. Try Grok Imagine, free for a limited time.
766
3K
10K
Link to the paper: Thanks to all colleagues involved !.
jhltonline.org
We identified and validated FEV1 trajectories that capture different clinical scenarios associated with post-transplant recipient outcomes. Our results may provide the basis for a trajectory-based...
0
0
3
New @ParisTxGroup paper released in @TheJHLT with @drAntoineRoux @AlexandreLoupy ! .🌍 15 centers / 4 countries.👥2,300+ lung recipients.📈 Identification of universal FEV1 trajectories associated with outcomes. A step toward trajectory-based monitoring #Transplantation #AI
1
3
10
This study shows how #MetaResearch helps map progress, expose gaps, and guide future directions. Big congrats to Ivana Juric 🙌.Thanks to all co-authors & collaborators for the amazing team effort!
0
0
3
📈 Two peaks in research:.🔬 1990s – gene editing boom.🧪 2020s – first pig-to-human kidney transplants.But today’s surge is mostly reviews, not original data. 🛡 Immunological barriers = most discussed challenge. 📚 Research still siloed in transplant journals.
1
0
2
📢 New publication in Xenotransplantation Journal by our group @ParisTxGroup @AlexandreLoupy !. Among the 2,900+ Xeno papers we assessed, 706 focused on solid organ & islet transplants from animals to humans 🐷➡️🧍. Here’s a summary of what we found 👇.
lnkd.in
This link will take you to a page that’s not on LinkedIn
2
3
12
3/3 🚀With multicenter validation (17 centers, 14,032 biopsies), the VBS is a tool to optimize kidney allocation globally. 🌍 We encourage further trials to show relevance in additional settings.
0
0
1
2/3 🔍Giorgakis et al. raised concerns about false positives in high-risk settings. 👉 While biopsies remain critical for complex cases, VBS is performant at identifying low-risk kidneys, safely omitting unnecessary biopsies and enabling quicker decisions. 🌟 VBS AUC range =.
1
0
3
1/3 💡 What is the Virtual Biopsy System (VBS)?.The VBS aims to reduce inefficiencies in preimplantation biopsies by predicting Banff lesions using donor data. The objective is to fast-track organ allocation, reduce cold ischemia time, and improve transplant outcomes.
1
0
1
🚨 Just published in @NatureComms ! Our response with @DivardG and @AlexandreLoupy to the letter by Giorgakis et al. addresses the application of the Virtual Biopsy System for kidney transplants. Let's dive in! 👇.
1
0
7
🙌 Truly an amazing adventure. What a chance to work with such a talented team!.
📢 Just published in @NEJM and presented at @ASNKidney #KidneyWk: Our study, analyzing over 16,000 biopsies from 30+ centers, provides insight into microvascular inflammation in kidney allografts. @AlexandreLoupy.🙌 to @MartaSablik @A_Sannier @Raynaud_Maths.Let’s dive into it 👇.
0
1
8
Listening to Kevin Fowler @gratefull080504 a kidney recipient himself, on how involving patients in the clinical trial discussion #Banff2024.Leveraging the patient voice will help solve problems. @univ_paris_cite @ParisTxGroup
1
1
7
Today, I stand at the war memorial at @Univ_Paris_Cite, dedicated to the physicians and medical students who gave their lives for France during WWI. As we gather for #Banff2024, their sacrifices remind us of the commitment to saving lives.🕊️🇫🇷 #PITOR #UPCité @ParisTxGroup
0
1
14
And for the last day of @ATCMeeting, at the plenary session, we have THE @zpdemir2, who shows the associations between HLA immunogenicity and AMR. @ParisTxGroup #ATC2024Philly @APHP @AST_info
0
3
16
Excited to attend a unique philosophical session @ATCmeeting, exploring deep questions: What is death? 💀 What is courage? 💪 What is a human? 🧬 Fascinating to see these profound discussions in the context of organ transplantation. #ATC2024Philly.@ParisTxGroup @APHP @AST_info
0
0
9
R Broussy is showing the impact of glomerulonephritis recurrence on kidney allograft survival. A very rare and insightful population-based study !.@brousse_romain @ParisTxGroup @ATCMeeting #ATC2024Philly
0
2
11
Amazing time with Vishnu Potluri from #Philadelphia who showed me the immense #Penn campus. Even got the chance to take a picture with Benjamin Franklin !.@ATCMeeting @ParisTxGroup @PeterPReese1 @AlexandreLoupy #ATC2024Philly
0
0
11
The Late Breaking Clinical Trials is about to start. Looking forward to the talks, especially the one of Carmen Lefaucheur about #iBox to guide decision making in routine practice. @ATCMeeting @ParisTxGroup #RCT
0
2
12
What’s happening ?! Is Paris Transplant Group taking over the AMR session @ATCMeeting ? Looks like it with four presentations given by @MartaSablik @DivardG and Michelle Elias. @ParisTxGroup #ATC2024Philly
0
5
27